MedTrace Logo

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

NCT00435461 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2018-03-07

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine

Conditions

  • Rhinitis, Allergic, Seasonal

Interventions

DRUG

Fluticasone furoate and fexofenadine

Fluticasone furoate and fexofenadine

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-20
Primary Completion
2007-02-01
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00435461 on ClinicalTrials.gov